On Friday, Tandem Diabetes Care Inc (NASDAQ: TNDM) was -6.86% drop from the session before settling in for the closing price of $21.28. A 52-week range for TNDM has been $15.75 – $53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 21.01% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 6.85%. With a float of $65.98 million, this company’s outstanding shares have now reached $66.57 million.
In an organization with 2650 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 46.57%, operating margin of -16.18%, and the pretax margin is -15.82%.
Tandem Diabetes Care Inc (TNDM) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tandem Diabetes Care Inc stocks. The insider ownership of Tandem Diabetes Care Inc is 0.95%, while institutional ownership is 111.52%. The most recent insider transaction that took place on Mar 07 ’25, was worth 190,966. In this transaction EVP & Chief Operating Officer of this company bought 10,538 shares at a rate of $18.12, taking the stock ownership to the 10,538 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director sold 30,000 for $31.38, making the entire transaction worth $941,400. This insider now owns 165,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 6.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 67.20% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
You can see what Tandem Diabetes Care Inc (TNDM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.39 million. That was inferior than the volume of 1.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.81%. Additionally, its Average True Range was 1.09.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 18.06%, which indicates a significant increase from 2.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.40% in the past 14 days, which was lower than the 88.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.64, while its 200-day Moving Average is $31.09. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $21.01. Second resistance stands at $22.20. The third major resistance level sits at $22.85. If the price goes on to break the first support level at $19.17, it is likely to go to the next support level at $18.52. Assuming the price breaks the second support level, the third support level stands at $17.33.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are 66,607K outstanding shares of the company, which has a market capitalization of 1.32 billion. As of now, sales total 940,200 K while income totals -96,030 K. Its latest quarter income was 234,420 K while its last quarter net income were -130,560 K.
